Navigation Links
China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2012
Date:11/28/2011

ntial", "predict", "should" or "will" or the negative of these terms or other comparable terminology. These statements are only predictions, uncertainties and other factors may cause the Company's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. The information in this press release is not intended to project future performance of the Company. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company does not guarantee future results, levels of activity, performance or achievements. The Company expectations are as of the date this press release is issued, and the Company does not intend to update any of the forward-looking statements after the date this press release is issued to confirm these statements to actual results, unless required by law.

The forward-looking statements included in this press release are subject to risks, uncertainties and assumptions about the Company's businesses and business environments. These statements reflect the Company's current views with respect to future events and are not a guarantee of future performance. Actual results of the Company's operations may differ materially from information contained in the forward-looking statements as a result of risk factors some of which include, among other things: continued compliance with government regulations regarding cord blood banking in the People's Republic of China, or PRC; changing legislation or regulatory environments in the PRC; the acceptance by subscribers of the Company's different pricing and payment options and reaction to the introduction of the Company's premium-quality pricing strategy; demographic trends in the regions of the PRC in which the Company is the exclusive licensed cord blood banking operator; labor and personnel relatio
'/>"/>

SOURCE China Cord Blood Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. China Nepstar Chain Drugstore Reports Third Quarter 2011 Financial Results
2. Sinovac to Present at 23rd Annual Piper Jaffray Health Care Conference and HK/China Mini Conference 2011 (Healthcare)
3. China Health Resource Announces Record Breaking 3rd Quarter 2011 Financial Results
4. China Medical Technologies Reports Second Fiscal Quarter Financial Results
5. The Outlook for Pharmaceuticals in Brazil, Russia, India & China
6. RNL Opens the Worlds Largest Stem Cell Medical Center in Beijing, China
7. Intergraph® Technology Enables Bayer Technology Services to Engineer New Plant in China
8. China Medical Technologies Announces Payment on Maturity and Cancellation of its 3.5% Convertible Senior Subordinated Notes due November 15, 2011
9. Winner Medical to Participate in Upcoming Investor Conferences in China
10. China Kanghui Holdings Reports Third Quarter 2011 Financial Results
11. China Sky One Medical Announces Third Quarter 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... DUBLIN , Dec. 22, 2014 Research ... announced the addition of the "Investment Analysis ... report to their offering. ... investments in the US medical device sector identifies ... equity and venture capital investments, and mergers and ...
(Date:12/22/2014)... Cyberonics, Inc. (NASDAQ: CYBX ), a ... of epilepsy, today announced it will participate in the 33 ... 14, 2015, in San Francisco . ... Officer, will speak at 11:00 AM Pacific Time.  A live ... on the Investor Relations link on the Cyberonics home page ...
(Date:12/22/2014)... 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: ... developing and commercializing innovative therapies addressing major unmet ... following open letter to shareholders from President & ... Dear RXi Shareholders, In ... statements posted on certain social media sites seem ...
Breaking Medicine Technology:Investment Analysis of the US Medical Device Sector 2RXi Pharmaceuticals Issues Open Letter to Shareholders 2RXi Pharmaceuticals Issues Open Letter to Shareholders 3RXi Pharmaceuticals Issues Open Letter to Shareholders 4RXi Pharmaceuticals Issues Open Letter to Shareholders 5RXi Pharmaceuticals Issues Open Letter to Shareholders 6
... , June 21 Ethicon Endo-Surgery, Inc. ... line of surgical devices, the HARMONIC ACE® 45 cm ... the reach of surgeons for minimally invasive procedures involving ... the standard length HARMONIC ACE® device. The additional length ...
... 21 Pfizer Inc. (NYSE: PFE ) announced today ... it will be discontinuing commercial availability of Mylotarg® (gemtuzumab ozogamicin for Injection) ... the United States and that it will be voluntarily withdrawing the ... , , , ...
Cached Medicine Technology:Ethicon Endo-Surgery Introduces HARMONIC ACE® 45 cm Curved Shears at ASMBS 2Ethicon Endo-Surgery Introduces HARMONIC ACE® 45 cm Curved Shears at ASMBS 3Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg® 2Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg® 3Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg® 4Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg® 5Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg® 6
(Date:12/26/2014)... London, England (PRWEB) December 26, 2014 ... to take place March 24-28, 2015 in Rome, Italy ... years' line-up includes workshops on a wide ... insomnia, as well as peak performance training in athletes. ... from around the world. , Biofeedback monitoring allows clients ...
(Date:12/26/2014)... DW-InductionHeating.com (DaWei Induction Heating Co.) is a comprehensive ... and marketing of a series of induction heating equipment. ... series of induction brazing equipments . , According ... brazing refers to the joining of two or ... The manager says that there are fundamental differences in ...
(Date:12/25/2014)... 26, 2014 The report “Nintedanib ... 2023” focuses on the current treatment landscape, unmet ... colorectal cancer market. Stivarga is a drug which ... rectal cancer. Boehringer Ingelheim is developing nintedanib (BIBF-1120), ... of refractory CRC in the US, Europe, and ...
(Date:12/25/2014)... 2014 Recently, Dylan Queen, a famous ... released its collection of discounted prom dresses, most of ... senior spokesman of the company, the promotion is valid ... is to expand the UK market. , The prom ... colors, lengths, and styles: A-line strapless, empire strapless chiffon, ...
(Date:12/25/2014)... Miami, FL (PRWEB) December 25, 2014 When ... often find themselves in a frenzy to get rid of ... classroom. But families in Coral Gables now have the solution ... its second salon clinic location, Lice Troopers provides full spectrum ... in the Coral Gable area, including Sunset, Key Biscayne, Brickell, ...
Breaking Medicine News(10 mins):Health News:Final Workshop Line-up Announced for 18th Annual Biofeedback Conference in Rome, Italy 2Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2
... Mass. - In a paper that suggests a new strategy ... colleagues report that the influenza virus infection in young mice ... asthma. The same protective effect was achieved by treating young ... ( H. pylori ), a bacterium that colonizes the ...
... 13 (HealthDay News) -- Exposure to a mineral found on ... of a type of lung cancer called mesothelioma, says a ... ash that has been altered by weathering and ground water, ... formations. It looks like transparent, glass-like fibers. Erionite has similar ...
... is available in French . Montreal, December ... significance has become loaded in our society, according to Anthony ... and Anthropology. In his most recent book, Re-Thinking Men: Heroes, ... men are to assume in society. Synnott spent ...
... HealthDay Reporter , FRIDAY, Dec. 10 (HealthDay News) ... type of breast cancer could potentially usher the majority ... breast cancer meeting said Friday. Presenting results from ... Symposium, scientists explained that administering two or more drugs ...
... frustrated by the lack of a meaningful way to screen ... that often progresses with few symptoms until it is too ... most commonly used biomarker used in screening, CA125, are also ... Duke Cancer Institute say that incorporating the latest information about ...
... higher prescription co-payment, especially among older women, is ... adjuvant aromatase inhibitor therapy, a life-saving therapy for women ... Dawn L. Hershman, MD, associate professor of medicine and ... the Herbert Irving Comprehensive Cancer Center at Columbia University, ...
Cached Medicine News:Health News:Study shows how flu infections may prevent asthma 2Health News:Study shows how flu infections may prevent asthma 3Health News:Road Material in N. Dakota May Up Lung Cancer Risk: Study 2Health News:This is a man's world? Yes and no, says new book 2Health News:Certain Drug Combinations May Beat Back Aggressive Breast Cancer 2Health News:Certain Drug Combinations May Beat Back Aggressive Breast Cancer 3Health News:Biological diversity of ovarian cancer lessens value of screening 2Health News:Higher co-payments increase chance of early discontinuation of breast cancer therapy 2
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,407-0) or contact custom...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
... is the #1 Pipettor for sub-microliter ... and reliability. Continuously adjustable. Features lPLUS, ... Easy interchangeable ejector buttons to fit ... rapid pipet tip ejector with three ...
... digital models cover the range from 2ul to ... Volume lock design prevents inadvertent volume change. ... grip. Whole pipette is autoclavable at 121C(250F). ... all polypropylene. Suitable for one-handed operation. ...
Medicine Products: